844
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines

Seroprevalence of tetanus and pertussis antibodies among health care workers in Wuhu, China

, , , , , , , & ORCID Icon show all
Article: 2318892 | Received 07 Nov 2023, Accepted 12 Feb 2024, Published online: 11 Mar 2024

References

  • Centers for Disease Control and Prevention. Tetanus. [accessed 2023 Sep 5]. https://www.cdc.gov/tetanus/.
  • Centers for Disease Control and Prevention. Pertussis (whooping cough). [accessed 2023 Sep 5]. https://www.cdc.gov/pertussis/.
  • World Health Organization (WHO). Immunization data: comparison of immunization coverage for DTP vaccination coverage and reported cases for tetanus. [accessed 2024 Jan 5]. https://immunizationdata.who.int/compare.html?COMPARISON=type1__WIISE/MT_AD_COV_LONG+type2__WIISE/MT_AD_INC_LONG+option1__DTP_coverage+option2__TTETANUS_cases&CODE=CHN&YEAR=.
  • Yao K. Immunization to prevent non-neonatal tetanus. Zhonghua Er Ke Za Zhi. 2020;58(3):259–7. doi:10.3760/cma.j.issn.0578-1310/2020.03.024. (In Chinese).
  • Wang C, Liu S, Shao Z, Yin Z, Chen Q, Ma X, Ma C, Wang Q, Wang L, Deng J. et al. Guidelines for the use of post-traumatic tetanus vaccines and passive immune preparation. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):167–72. doi:10.3760/cma.j.issn.0254-6450.2020.02.006. (In Chinese).
  • PERISCOPE Consortium. PERISCOPE: road towards effective control of pertussis. Lancet Infect Dis. 2019;19(5):179–86. doi:10.1016/S1473-3099(18)30646-7.
  • Winter K, Glaser C, Watt J, Harriman K. Pertussis epidemic–California, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1129–32.
  • Marshall KS, Quinn HE, Pillsbury AJ, Maguire JE, Lucas RM, Dey A, Beard FH, Macartney KK, Mcintyre PB. Australian vaccine preventable disease epidemiological review series: pertussis, 2013–2018. Commun Dis Intell (2018). 2022;46. doi:10.33321/cdi.2022.46.3.
  • World Health Organization (WHO). Immunization data: comparison of immunization coverage for DTP vaccination coverage and reported cases for pertussis. [accessed 2023 Sep 5]. https://immunizationdata.who.int/compare.html?COMPARISON=type1__WIISE/MT_AD_COV_LONG+type2__WIISE/MT_AD_INC_LONG+option1__DTP_coverage+option2__PERTUSSIS_cases&CODE=CHN&YEAR=.
  • Sheridan SL, Frith K, Snelling TL, Grimwood K, Mcintyre PB, Lambert SB. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Rev Vaccines. 2014;13(9):1081–106. doi:10.1586/14760584.2014.944167.
  • Mcgirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015;135(2):331–43. doi:10.1542/peds.2014-1729.
  • Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA. et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 2013;131(4):e1047–52. doi:10.1542/peds.2012-1928.
  • Plans-Rubió P. Vaccination coverage for routine vaccines and herd immunity levels against measles and pertussis in the World in 2019. Vaccines (Basel). 2021;9(3):256. doi:10.3390/vaccines9030256.
  • De Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, Van Der Zee A, Schellekens JF. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with bordetella pertussis. J Clin Microbiol. 2000;38(2):800–6. doi:10.1128/JCM.38.2.800-806.2000.
  • Zhang J, Deng J, Yang Y. Pertussis vaccination in Chinese children with increasing reported pertussis cases. Lancet Infect Dis. 2022;22(1):21–2. doi:10.1016/S1473-3099(21)00752-0.
  • Zhang C, Hu W, Wang R, Wang Y, Li Y, Lv Y, Li W, Si Y, Zhang S. Seroepidemiology of pertussis and diphtheria among healthy adults in Shaanxi Province, Northwest China: a large - scale cross-sectional study. Hum Vaccin Immunother. 2022;18(6):2133913. doi:10.1080/21645515.2022.2133913.
  • Liu D, Cheng X, Wei S, Yuan L, Chen C, Yao K. Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China. Hum Vaccin Immunother. 2021;17(6):1757–62. doi:10.1080/21645515.2020.1840253.
  • Chen Z, Pang J, Zhang N, Chen N, Ding Y, He Q. Seroprevalence study of pertussis in adults at childbearing age and young infants reveals the necessity of booster immunizations in adults in China. Vaccines (Basel). 2022;10(1):84. doi:10.3390/vaccines10010084.
  • Zhang Z, Pan J, Chen M, Zhang T, Li J, Lu L. Seroepidemiology of pertussis in China: a population-based, cross-sectional study. Vaccine. 2021;39(12):1687–92. doi:10.1016/j.vaccine.2021.02.032.
  • Meng Q, Oian Q, Li L, Liu D, Gao W, Yuan L, Yao K. The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China. BMC Pediatr. 2019;19(1):480. doi:10.1186/s12887-019-1860-5.
  • European Centre for Disease Prevention and Control (ECDC). Laboratory diagnosis and molecular surveillance of Bordetella pertussis. Stockholm: ECDC; 2022.
  • Subissi L, Rodeghiero C, Martini H, Litzroth A, Huygen K, Leroux-Roels G, Piérard D, Desombere I. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects. Clin Microbiol Infect. 2020;26(5):645. doi:10.1016/j.cmi.2019.10.001.
  • Chen Z, Liu X, Zhang Y, Peng X, Zhang N, Chen N, Li Y, He Q. Evaluation of serum anti-pertussis toxin IgA antibodies for the diagnosis of bordetella pertussis infection in young children. J Infect Public Health. 2023;16(8):1167–1173. doi:10.1016/j.jiph.2023.05.028.
  • Warrener L, Bwogi J, Andrews N, Samuel D, Kabaliisa T, Bukenya H, Brown K, Roper MH, Featherstone DA, Brown D. Serum anti-tetanus and measles antibody titres in Ugandan children aged 4 months to 6 years: implications for vaccine programme. Epidemiol Infect. 2018;146(9):1151–6. doi:10.1017/S0950268818000948.
  • Zhang Y, Chen Z, Zhao J, Zhang N, Chen N, Zhang J, Li S, He Q. Increased susceptibility to pertussis in adults at childbearing age as determined by comparative seroprevalence study, China 2010–2016. J Infect. 2019;79(1):1–6. doi:10.1016/j.jinf.2019.04.011.
  • Chen Q, Wang W, Shi X, Xu Y, Zhu Y, Wu Y, Wang Z, Sun H, Sun X. Seroepidemiology of pertussis in the East of China: estimates of incidence of infection in adolescents and adults pre- and post-COVID-19. Front Public Health. 2022;10:1054617. doi:10.3389/fpubh.2022.1054617.
  • He H, Zhu Y, Jin M, Zhou Y, Tang X, Yan R, Deng X, Chen K. The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: a cross-sectional sero-epidemiological study. Vaccine. 2022;40(48):6956–62. doi:10.1016/j.vaccine.2022.10.020.
  • Zhang Q, Han F, Nie Q, Ren H, Zhang B, Liu Q, He Q, Shao Z. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. J Infect. 2011;63(6):441–6. doi:10.1016/j.jinf.2011.07.018.
  • Wang CQ, Zhu QR. Seroprevalence of bordetella pertussis antibody in children and adolescents in China. Pediatr Infect Dis J. 2011;30(7):593–6. doi:10.1097/INF.0b013e31820eaf88.
  • Chen Z, Pang J, Zhang Y, Ding Y, Chen N, Zhang N, He Q. Seroprevalence of pertussis in adults at childbearing age pre- and post- COVID-19 in Beijing, China. Vaccines (Basel). 2022;10(6):872. doi:10.3390/vaccines10060872.
  • Macina D, Evans KE. Bordetella pertussis in school-age children, adolescents, and adults: a systematic review of epidemiology, burden, and mortality in Asia. Infect Dis Ther. 2021;10(3):1115–40. doi:10.1007/s40121-021-00439-1.